首页> 外国专利> INHIBITORS OF THE T CELL-SPECIFIC ALTERNATIVE P38 ACTIVATION PATHWAY AND METHODS OF USE

INHIBITORS OF THE T CELL-SPECIFIC ALTERNATIVE P38 ACTIVATION PATHWAY AND METHODS OF USE

机译:T细胞特异性P38激活途径的抑制剂及其使用方法

摘要

In T lymphocytes, p38 mitogen activated protein kinase (MAPK) can be activated through an alternative pathway that involves phosphorylation at tyrosine 323. Disclosed herein is the identification of a minimal region of the growth arrest and DNA damage-inducible alpha (Gadd45α) protein that is required for binding to and inhibition of tyrosine 323-phosphorylated p38 in T cells. The disclosed Gadd45α polypeptides inhibit proliferation of T cells in response to T cell receptor stimulation, inhibit differentiation of T cells into Th1 or Th17 cells, inhibit the production of proinflammatory cytokines, and reduce tumor formation and growth of inflammatory cancers, such as pancreatic cancer.
机译:在T淋巴细胞中,p38丝裂原激活的蛋白激酶(MAPK)可以通过涉及酪氨酸323磷酸化的另一种途径被激活。本文揭示了生长停滞和DNA损伤诱导性α(Gadd45α)蛋白质的最小区域的识别。在细胞中结合和抑制酪氨酸323-磷酸化的p38是必需的。所公开的Gadd45α多肽响应于T细胞受体刺激而抑制T细胞的增殖,抑制T细胞分化为Th1或Th17细胞,抑制促炎细胞因子的产生,并减少肿瘤形成和炎性癌症例如胰腺癌的生长。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号